Implementation of the INNO-LiPA Rif.TB® line-probe assay in rapid detection of multidrug-resistant tuberculosis in Latvia

International Journal of Tuberculosis and Lung Disease

Volumn 15, Issue 11, 2011, Pages 1546-1552

  Šķenders, Ģirts ^a   Holtz, T H ^b   Riekstina, V ^a   Leimane, V ^c  

^a State Agency Infectology Center of Latvia   (Latvia)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Drug resistance; Line probe assay; Rapid detection; Tuberculosis

Indexed keywords

RIFAMPICIN;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM DETECTION; BACTERIUM ISOLATION; BIOASSAY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DRUG EFFICACY; EARLY DIAGNOSIS; FEMALE; HUMAN; INFECTION RISK; INTERMETHOD COMPARISON; LATVIA; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SPUTUM CULTURE; SPUTUM SMEAR;

ADOLESCENT; ADULT; ANTIBIOTICS, ANTITUBERCULAR; CHI-SQUARE DISTRIBUTION; DNA MUTATIONAL ANALYSIS; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GENOTYPE; HUMANS; LATVIA; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MUTATION; MYCOBACTERIUM TUBERCULOSIS; PHENOTYPE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROGRAM EVALUATION; RIFAMPIN; SPUTUM; TIME FACTORS; TUBERCULOSIS, MULTIDRUG-RESISTANT; YOUNG ADULT;

EID: 80053947408     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.11.0067     Document Type: Article

References (26)

1. World Health Organization. Multidrug and extensively drugresistant TB (M/XDR-TB): 2010 global report on surveillance and response. WHO/HTM/TB/2010.3. Geneva, Switzerland: WHO, 2010.
2. Centers for Disease Control and Prevention. Emergence of Mycobacterium tuberculosis with extensive resistance to secondline drugs - worldwide, 2000-2004. Morb Mortal Wkly Rep 2006; 55: 301-305.
3. Nathanson E, Nunn P, Uplekar M, et al. MDR tuberculosis - critical steps for prevention and control. N Engl J Med 2010; 363: 1050-1058.
4. Quezada C M, Kamanzi E, Mukamutara J, et al. Implementation validation performed in Rwanda to determine whether the INNO-LiPA Rif.TB line-probe assay can be used for detection of multidrug-resistant Mycobacterium tuberculosis in lowresource countries. J Clin Microbiol 2007; 45: 3111-3114. (Pubitemid 47417369)
5. Piersimoni C, Scarparo C, Callegaro A, et al. Comparison of MB/Bact alert 3D system with radiometric BACTEC system and Löwenstein-Jensen medium for recovery and identifi cation of mycobacteria from clinical specimens: a multicenter study. J Clin Microbiol 2001; 39: 651-657. (Pubitemid 32150835)
6. Cruciani M, Scarparo C, Malena M, Bosco O, Serpelloni G, Mengoli C. Meta-analysis of BACTEC MGIT 960 and BACTEC 460 TB, with or without solid media, for detection of mycobacteria. J Clin Microbiol 2004; 42: 2321-2325. (Pubitemid 38637876)
7. World Health Organization. Use of liquid TB culture and drug susceptibility testing (DST) in low- and medium-income settings. Geneva, Switzerland: WHO, 2007.
8. Balabanova Y, Drobniewski F, Nikolayevskyy V, et al. An integrated approach to rapid diagnosis of tuberculosis and multidrug resistance using liquid culture and molecular methods in Russia. PLoS One 2009; 4: e7129.
9. Chihota V N, Grant A D, Fielding K, et al. Liquid vs. solid culture for tuberculosis: performance and cost in a resourceconstrained setting. Int J Tuberc Lung Dis 2010; 14: 1024-1031.
10. Barnard M, Albert H, Coetzee G, O'Brien R, Bosman M E. Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Am J Respir Crit Care Med 2008; 177: 787-792. (Pubitemid 351490566)
11. Morgan M, Kalantri S, Flores L, Pai M. A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a systematic review and metaanalysis. BMC Infect Dis 2005; 5: 62.
12. Bicmen C, Gunduz A T, Coskun M, et al. Molecular identifi cation and characterization of rifampicin-resistant Mycobacterium tuberculosis isolates by line-probe assay: an approach for rapid diagnosis of multidrug-resistant tuberculosis. Lett Appl Microbiol 2008; 47: 214-220.
13. Caws M, Drobniewski F A. Molecular techniques in the diagnosis of Mycobacterium tuberculosis and the detection of drug resistance. Ann N Y Acad Sci 2001; 953: 138-145. (Pubitemid 34072987)
14. Cavusoglu C, Hilmioglu S, Guneri S, Bilgic A. Characterization of rpoB mutations in rifampin-resistant clinical isolates of Mycobacterium tuberculosis from Turkey by DNA sequencing and line probe assay. J Clin Microbiol 2002; 40: 4435-4438. (Pubitemid 35434927)
15. Traore H, van Deun A, Shamputa I C, Rigouts L, Portaels F. Direct detection of Mycobacterium tuberculosis complex DNA and rifampin resistance in clinical specimens from tuberculosis patients by line probe assay. J Clin Microbiol 2006; 44: 4384-4388. (Pubitemid 44937068)
16. Viveiros M, Leandro C, Rodrigues L, et al. Direct application of the INNO-LiPA Rif.TB line-probe assay for rapid identification of Mycobacterium tuberculosis complex strains and detection of rifampin resistance in 360 smear-positive respiratory specimens from an area of high incidence of multidrug-resistant tuberculosis. J Clin Microbiol 2005; 43: 4880-4884. (Pubitemid 41298302)
17. Johansen I S, Lundgren B, Sosnovskaja A, Thomsen V O. Direct detection of multidrug-resistant Mycobacterium tuberculosis in clinical specimens in low- and high-incidence countries by line probe assay. J Clin Microbiol 2003; 41: 4454-4456. (Pubitemid 37099730)
18. Shah N S, Lan N T, Huyen M N, et al. Validation of the lineprobe assay for rapid detection of rifampicin-resistant Mycobacterium tuberculosis in Vietnam. Int J Tuberc Lung Dis 2009; 13: 247-252.
19. Sam I C, Drobniewski F, More P, Kemp M, Brown T. Mycobacterium tuberculosis and rifampin resistance, United Kingdom. Emerg Infect Dis 2006; 12: 752-759. (Pubitemid 43739339)
20. Skenders G, Fry A M, Prokopovica I, et al. Multidrug-resistant tuberculosis detection, Latvia. Emerg Infect Dis 2005; 11: 1461-1463. (Pubitemid 41209148)
21. O'Riordan P, Schwab U, Logan S, et al. Rapid molecular detection of rifampicin resistance facilitates early diagnosis and treatment of multidrug-resistant tuberculosis: case control study. PLoS One 2008; 3: e3173.
22. Acuna-Villaorduna C, Vassall A, Henostroza G, et al. Coste ffectiveness analysis of introduction of rapid, alternative methods to identify multidrug-resistant tuberculosis in middleincome countries. Clin Infect Dis 2008; 47: 487-495.
23. World Health Organization. Molecular line-probe assays for rapid screening of patients at risk of multidrug-resistant tuberculosis. Geneva, Switzerland: WHO, 2008.
24. Canetti G, Fox W, Khomenko A, et al. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull World Health Organ 1969; 41: 21-43.
25. Leimane V, Dravniece G, Riekstina V, et al. Treatment outcome of multidrug/extensively drug-resistant tuberculosis in Latvia, 2000-2004. Eur Respir J 2010; 36: 584-593.
26. Keshavjee S, Farmer P E. Time to put boots on the ground: making universal access to MDR-TB treatment a reality. Int J Tuberc Lung Dis 2010; 14: 1222-1225.